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Abstract
This chapter focuses on the principle of electrophoresis and its utilization in 
a clinical laboratory. A sincere attempt has been made to discuss about clinical 
applications of serum protein electrophoresis, throwing light on the significance of 
serum protein electrophoresis in the management of multiple myeloma. Emphasis 
has been made on quality assurance in terms of accuracy and precision in elec-
trophoresis to ensure reliability of patient results. A note on issues with lack of 
standardization of reporting of electrophoresis and an insight into global efforts to 
standardize the reporting of the assay has been included in this chapter.
Keywords: electrophoresis, gamma globulins, polyclonal, oligoclonal, biclonal, 
myeloma
1. Introduction
Serum protein electrophoresis is an electrophoretic method of separating 
proteins present in the serum to various fractions based on their molecular weight 
and electric charges. Electrophoresis had been widely used in clinical medicine for 
aiding in diagnosis of various clinical conditions like acute and chronic inflamma-
tions, monoclonal gammopathies, nephropathy, liver diseases, etc. This chapter 
discusses the clinical applications of serum protein electrophoresis [1] including the 
quality control practices and its implications [2].
2. Principle
The separation of proteins by electrophoresis is based on the fact that charged 
molecules usually migrate through a matrix/medium upon application of an electri-
cal field [3]. The rate at which proteins move in an electric field is determined by a 
number of factors of the electrophoretic system and the nature of proteins itself. 
Some factors to mention are the strength of the electric field, temperature of the 
system, pH of the ions, concentration of buffer etc. [4]. Proteins vary in their size 
and shape and have the charges determined by the dissociation contents of their 
amino acids. Smaller proteins usually migrate faster, and larger proteins take a 
longer time. This physical property of proteins is exploited for its separation by 
employing the electrophoretic technique.
The most commonly employed variant of electrophoresis for serum protein sepa-
ration is zone electrophoresis in which the serum proteins are separated into zones or 
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fractions and interpreted accordingly [5]. There are several support mediums avail-
able for separation of serum proteins including agarose, cellulose acetate, capillary 
medium etc. [6]; when a capillary medium is used, the technique is known as capil-
lary zone electrophoresis (CZE). Capillary electrophoresis is the preferred method 
when compared to its competitors including agarose gel electrophoresis due to the 
following reasons. CZE provides an improved resolution due to the following factors:
a. The use of “electroendosmosis” principle which improves the resolution of 
separation
b. Employing a “high-voltage” electric current which aids in improving the 
throughput (the processing time) and the resolution of protein separation.
Below is an illustration of capillary electrophoresis (Sebia Minicap Flex Piercing) 
(Figure 1). Sebia Minicap Flex Piercing capillary electrophoresis works on the 
principle of capillary electroendosmosis under high-voltage electric current. The Flex 
Piercing model of Sebia CZE aids in testing of human blood with capped tubes which 
in turn eliminates the biohazard xassociated with handling of uncapped samples.
3. Revisiting the basics: an insight into the protein family
Serum proteins are a family of albumin and globulins. Albumin is the major 
fraction synthesized from human liver endogenously and available through various 
dietary sources exogenously including egg, meat, pulses, milk etc. Globulins are a 
group of proteins subclassified into alpha-1, alpha-2, beta-1, beta-2, and gamma 
globulins based on the electrophoretic mobility (Figure 2). The normal biological 
interval of serum total proteins in a healthy adult ranges between 6 and 8 g/dl which 
includes Serum Albumin: 3.5–4.5 g/dl and Globulins: 2.5–3.5 g/dl.
3.1 Albumin
Albumin is a 69 kDa protein. It is the most abundant protein in serum. Albumin 
is synthesized in the liver and functions as a transport protein of various substances 
like bilirubin, enzymes, hormones, drugs etc. It also maintains fluid volume within 
the vascular space. Albumin is the first protein fraction to appear near the anode in 
Figure 1. 
Sebia Minicap flex piercing capillary electrophoresis.
3Serum Protein Electrophoresis and Its Clinical Applications
DOI: http://dx.doi.org/10.5772/intechopen.88367
SPE. Altered levels of serum albumin are associated with various clinical conditions. 
Low levels of albumin are clinically significant and are termed as hypoalbuminemia.
Decreased concentration of serum albumin (hypoalbuminemia) indicates either 
a poor dietary intake (malnutrition) or a decreased production or an increased loss. 
Chronic liver disease is a common clinical condition associated with decreased albu-
min production, and chronic kidney disease (CKD) is the most common disease 
associated with an increased loss of albumin in urine (proteinuria). This clinical 
condition is otherwise known as nephropathy. Other causes of hypoalbuminemia 
include acute and chronic inflammation, critical illness, pregnancy etc.
Apart from hypoalbuminemia which is commonly observed in an electrophoreto-
gram, there are a few variations which can be observed in the in albumin peak including:
a. Bilirubin, Triglycerides if present in high levels in serum may appear as a blunt 
peak which is seen adjacent to the cathode near the albumin peak.
b. Prealbumin (transthyretin)—increased levels of pre albumin, if present due to 
various clinical conditions including several inflammatory diseases is seen as a 
blunt anodal peak distinctly separated from the peak of albumin.
c. A rare variant observed in the albumin peak is bisalbuminemia which is a rare 
condition, with no clinical features, in which the serum contains two albumin 
variants of different electrophoretic mobilities, usually in equal concentra-
tions, though the total concentration of albumin is normal. Bisalbuminemia 
may be hereditary or acquired. The acquired type has been more frequently 
reported in chronic renal disease and pancreatitis and in patient with chronic 
renal disease. Two (rather than one) albumin bands may represent bisalbu-
minemia. Hereditary condition is a rare anomaly caused by a genetic lesion in 
the albumin gene usually a point mutation.
d. Analbuminemia (absence of albumin) is another genetically inherited meta-
bolic disorder and was first described in 1954. This disorder is rare and affects 
less than 1 in 1 million births.
The most important aspect of such albumin variants lies in quantification of an 
albumin peak in such scenarios followed by interpretation and clinical correlation 
(Figure 3).
Figure 2. 
Serum protein family with fractions.
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3.2 Alpha fraction
As electrophoresis proceeds toward the negative portion of the gel (cathode), 
the alpha zone is the next band after albumin. The alpha zone is subdivided into two 
zones: the alpha-1 peak and alpha-2 peak.
The alpha-1 peak consists of alpha-1 antitrypsin (AT), alpha-1-chymotrypsin, 
and thyroid-binding globulin. Alpha-1 antitrypsin is an acute-phase reactant. The 
concentration of alpha-1 antitrypsin increases in conditions of inflammation and 
is usually decreased in patients with alpha-1 antitrypsin deficiency or decreased 
production of globulin in patients with severe liver disease. A rare variant of alpha-1 
antitrypsin is encountered occasionally characterized by a split peak pattern of 
alpha-1 globulins.
The alpha-2 peak consists of alpha-2 macroglobulin, haptoglobin, and cerulo-
plasmin. Alpha-2 macroglobulin accounts for about 3% of the total protein in the 
serum. Because of the variable migration of the haptoglobin types, a2-macroglobu-
lin is often adjacent to, or co migrating with, haptoglobin and is therefore not seen 
as a discrete band.
A distorted pattern of alpha-2 region in electrophoresis is seen commonly in 
conditions of hemolysis, including in vivo and in vitro. The pathophysiology behind 
this pattern is the formation of hemoglobin-haptoglobin complexes in these condi-
tions. This is a physiological adaptive response by human physiology to conserve 
hemoglobin released as a result of RBC breakdown into circulation and hemoglobin 
being a smaller globular protein is bound to be lost in urine. Hence to preserve it, 
haptoglobin is consumed to form complex with hemoglobin which results in the 
formation of a macromolecular protein which is retained in circulation making 
hemoglobin available for the production of RBCs and prevention of anemia.
Haptoglobin and ceruloplasmin are acute-phase reactants, and hence increased 
in acute inflammatory states.
Alpha-2-macroglobulin is increased in nephrotic syndrome and cirrhosis of the 
liver. The elevation of alpha-2 macroglobulin is distinctly evident in nephritic syn-
drome, since it is a bulky molecule, and hence retained in circulation to compensate 
Figure 3. 
Abnormal electrophoretic patterns of albumin zone.
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for the loss of other proteins in urine which is evident in form of proteinuria in 
urine microscopic examination.
Ceruloplasmin is an important copper-binding transport protein produced by 
the liver. Ceruloplasmin concentrations are markedly decreased in conditions of 
Wilson’s disease. The disadvantage of serum protein electrophoresis is that it will 
not aid in the detection of a decreased ceruloplasmin.
3.3 Beta fraction
The beta zone usually is subdivided into two peaks, beta-1 and beta-2 in 
CZE. Beta-1 zone comprises proteins like transferrin and low-density lipoprotein 
(LDL).
Transferrin functions to transport non-heme ferric iron from the gastroin-
testinal tract. Each Transferrin molecule can bind two molecules of free iron. An 
increased beta-1 band is observed in iron deficiency anemia due to an increased 
level of free transferrin and also in pregnancy. Determinations of the transferrin 
levels are useful in distinguishing between iron deficiency anemia (inadequate 
intake or chronic hemorrhage with loss of iron stores) and hemolytic anemia, 
in which transferrin levels are low resulting in a beta-1 peak of low amplitude. 
Transferrin is usually decreased in alcoholic cirrhosis. Transferrin is also decreased 
during renal disease and thermal injuries.
The beta-2 band is mostly composed of complement proteins, C3 and C4. 
Elevated beta-2 zone can be caused in inflammatory states due to activation of 
complement cascade which include C3 and C4 too.
A reduced beta-2 peak intensity can be encountered in an aged sample, since 
the immune complexes are used up and low serum levels of complements are 
evidenced.
Fibrinogen is a protein with molecular weight of 340 kDa protein. Sometimes a 
small fibrinogen band can be seen in serum protein electrophoresis due to the insuffi-
cient clotting or failure to remove the serum from the clot. This fibrinogen band is seen 
between beta-1 and beta-2 regions. This band is also seen in patients who are receiving 
heparin therapy. It is also an important indicator of the sample type being analyzed. 
When plasma is used in the place of serum for protein electrophoresis, fibrinogen 
present in plasma appears in the beta-2 region, and this has the potentiality to interfere 
with the detection of monoclonal gammopathies in such patients (Figure 4).
3.4 Gamma fraction
One of the main clinical implications of serum protein electrophoresis is to aid 
diagnosis of disorders associated with alterations of gamma globulins. Gamma region 
comprises mainly of serum immunoglobulins. The five major classes of immunoglob-
ulins are IgG, IgA, IgM, IgD, and IgE. The immunoglobulins are characterized by the 
presence of two protein moieties named as heavy chain and light chain. The classifica-
tion of immunoglobulin had been made based on the composition of heavy chains, 
while the light chains are of two types including kappa or lambda. Physiologically, 
kappa forms the major light chain fraction among the two.
Various clinical conditions are associated with alteration of gamma globulins 
including:
a. Hypergammaglobinemia (increased serum gamma globulin levels)
b. Hypogammaglobinemia (decreased serum gamma globulin levels)
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Hypergammaglobinemia (gammopathies):
Gammopathy is defined as abnormal proliferation of the lymphoid cells produc-
ing immunoglobulins. There are four types of gammopathies: polyclonal, monoclo-
nal, biclonal, and oligoclonal.
Polyclonal gammopathies are defined as heterogeneous increase in immu-
noglobulins involving more than one cell line, commonly caused by a variety of 
inflammatory conditions (chronic inflammation), infections, chronic liver diseases 
(cirrhosis), chronic kidney diseases, etc.
Monoclonal gammopathies are characterized by a homogenous increase 
produced by clonal population of mature B cells, most commonly plasma cells. 
Monoclonal immunoglobulins seen in these conditions are also known as Para 
proteins. The classic interpretative terminology used in clinical laboratory medicine 
for describing a monoclonal immunoglobulin in SPE is “M” band where M stands 
for monoclonal. Common clinical disorders producing “M” Band in SPE include 
multiple myeloma and plasmacytoma in usually 60% of cases and Waldenströms 
Macroglobulinemia, lymphomas, and leukemia in approximately 10% of cases. 
Certain monoclonal gammopathies produce “M” band in electrophoretic regions 
other than in gamma regions, commonly being beta region especially in case of IgA 
and IgG myeloma.
Biclonal gammopathies are characterized by a double peak in the gamma region. 
This electrophoretic pattern is seen when there is a biclonal proliferation of immu-
noglobulins encountered in multiple myeloma. A biclonal pattern is also seen in 
monoclonal gammopathies associated with IgA and IgG. In such scenarios, these 
immunoglobulins appear as polymerized and monomerized forms which elute as 
biclonal peaks in gamma region or in beta region, respectively (Figure 5).
The oligoclonal pattern of gamma region is characterized by more than two 
peaks evident in the gamma region. This pattern is commonly seen in autoimmune 
disorders, light chain myelomas (characterized by clonal proliferation of light 
chains), amyloidosis, etc. (Figure 5).
Apart from serum immunoglobulin, C-reactive protein (CRP) also is evident in 
the gamma region. C-reactive proteins levels usually increase during inflammatory 
responses.
Apart from the common causes of altered electrophoresis picture specific to the 
particular zones, a sharp distinct peak when evident especially in beta or alpha region 
Figure 4. 
Fibrinogen producing a peak in beta 2 region (from a plasma sample).
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should raise a high index of diagnostic suspicion of multiple myeloma since a few 
monoclonal immunoglobulins shall migrate in these zones too, in contrary to the clas-
sical gamma zone M protein pattern, which is commonly reported in these conditions.
4. Role of SPE in multiple myeloma work-up
According to the International Myeloma Foundation, plasma cell dyscrasias are 
group of plasma cell disorders involving a wide spectrum of pathologies including:
1. MGUS—monoclonal gammopathy of undetermined significance
2. MGRS—monoclonal gammopathy of renal significance
3. Smoldering myeloma
4. Multiple myeloma (which includes various subtypes including nonsecretory 
myeloma (NSMM), light chain myeloma, secretory multiple myeloma)
Criteria for diagnosis and differentiation of the plasma cell disorders based on 
International Myeloma Working Group (IMWG) criteria:
1. Monoclonal gammopathy of undetermined significance (MGUS)
• M protein (Monoclonal band)—<3 g/dl
• Bone marrow biopsy—<10% plasma cells seen
Figure 5. 
Abnormal electrophoretic patterns of gamma zone.
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• No clinical symptoms/signs
• Normbal free light chain ratio in serum
2. Monoclonal gammopathy of renal significance (MGRS)
• M protein (monoclonal band)—<3 g/dl
• Bone marrow biopsy—<10% plasma cells seen
• Renal disease with elevated serum creatinine
• Normal Free light chain ratio in serum
3. Smoldering myeloma
• M protein (monoclonal band)—<3 g/dl
• Bone marrow biopsy—>10% plasma cells seen
• Abnormal free light chain ratio in serum
• Clinically significant. Clinical diagnosis includes a tetrad of “ÇRAB” 
which stands for (one of the four shall be present):
 ○ C—hypercalcemia
 ○ R—renal abnormalities (elevated creatinine)
 ○ A—anemia
 ○ B—bone lesions
4. Multiple myeloma
• M protein (monoclonal band)—>3 g/dl
• Bone marrow biopsy—>10% plasma cells seen
• Abnormal free light chain ratio in serum
• Clinical diagnosis includes a tetrad of “ÇRAB” which stands for (one of 
the four shall be present):
 ○ C—hypercalcemia
 ○ R—renal abnormalities (elevated creatinine)
 ○ A —anemia
 ○ B—bone lesions
There are exceptions in SPE findings in certain cases of multiple myeloma 
wherein the SPE does not reveal any significant alteration or a clue toward the 
diagnosis.
These variants of multiple myeloma characterized by an abnormal bone marrow 
(increased plasma cells) but a normal SPE are termed as nonsecretory myelomas 
9Serum Protein Electrophoresis and Its Clinical Applications
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which account to 1–2% of multiple myelomas. In such cases, an immunoassay of 
free light chains (FLC) in serum provides a diagnostic clue toward NSMM which 
show a significant disproportionate elevation of usually a clone of light chains 
(kappa or lambda) with an alteration in kappa/lambda ratio (normal Ratio is 
between 0.60 and 1.65). A commonly encountered phenomenon with laboratory 
testing of FLC includes “prozone” effect or “hook” effect which occurs due to 
antigen excess and requires appropriate dilution to obtain reliable results.
Bence-Jones protein estimation in urine is an antique piece of laboratory evi-
dence toward multiple myeloma, which is characterized by detection of light chains 
in urine. But since the methodology of testing is manual and does not provide stan-
dardization, this has been replaced by urine FLC analysis in laboratories practicing 
good clinical laboratory practices (GCLP).
One more valiant laboratory investigation which is an essential requisite for 
multiple myeloma work-up includes immunoelectrophoresis.
One common principle employed in immunoelectrophoretic technique involves 
the use of specific antihuman immunoglobulins (e.g., Anti-IgG, Anti-IgA, Anti-
Kappa, etc.) as a preprocessing step which results in precipitation of immunoglobu-
lins if present and disappearance of the band/peak contributed by that specific 
immunoglobulin. Hence this technique is also known as immunosubtraction. This 
technique aids in typing the specific type of immunoglobulin (including the type of 
light chain) contributing to myeloma. This technique is supplemented by quantifi-
cation of serum immunoglobulins by an immunoassay.
4.1 SPE and its clinical significance
SPE is a semiquantitative investigation which involves technical expertise to 
recognize the specific electrophoretic patterns and associate with various clinical 
conditions. This requires a laboratory practice integrated across various divisions of 
laboratory and with respective clinical and ancillary divisions of clinical medicine [1].
With respect to SPE, the laboratory professionals shall act as consultants to 
the clinical consultants. This is possible in scenarios where the clinician does not 
arrive at a provisional diagnosis of a gammopathy and the laboratory picks up the 
diagnostic clue toward gammopathy through an increased serum total protein 
level (<8 g/dl) and an altered serum albumin globulin (AG) ratio (which is usually 
altered in gammopathy). A normal AG ratio ranges between 1.2 and 1.8, while 
there is a significant reduction in the ratio in patients with gammopathy. This 
becomes an incidental finding which leads to a concept of “reflex” testing for 
multiple myeloma work-up including SPE, upon consent from the treating clini-
cian and the patient.
These are some of the common SPE patterns associated with various clinical 
conditions:
• Inflammation: Increased intensity of alpha-1 and alpha-2 with a sharp leading 
edge of alpha-1 may be observed, but with chronic inflammation the albumin 
band may be decreased with increased gamma zone due to the polyclonal 
gammopathy.
• Nephrotic syndrome: The albumin band is decreased due to hypoalbumin-
emia. In addition, the alpha-2 band may be more distinct.
• Cirrhosis or chronic liver disease: A low albumin band due to significant 
hypoalbuminemia with a prominent beta-2 band and beta-gamma bridging 
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is a characteristic feature. In addition, polyclonal hypogammaglobinemia is 
observed.
• Malnutrition: Decreased albumin levels [1].
• Alpha-1 antitrypsin deficiency: Inflammatory condition, pregnancy.
• Hemolysis: Altered electrophoretic pattern of small indistinct peaks in alpha-2 
region.
4.2 Quality assurance in SPE
Quality assurance in SPE is an essential prerequisite to ensure reliability of an 
SPE result [2]. There are two major aspects of analytical quality including precision 
(measure of precision) and accuracy (measure of trueness).
Good clinical laboratory practices demand processing of an internal quality 
control (IQC) for assessment of precision and external quality assurance (EQA)/
proficiency testing (PT testing) for accuracy assessment. IQC is a material which 
can be prepared in house (patient sample) or available commercially and is to be 
processed before a patient sample is taken up for processing.
The clinical laboratory has its responsibility to select and use an IQC which has 
a matrix comparable to patient sample, preferably covering the clinical decision 
point (cut off value that differentiates between a normal and abnormal result). 
EQA is an external assessment of the analytical quality wherein the laboratory 
processes a blinded sample and the results are compared against a reference 
method and/or against the consensus value of other participant laboratories for 
that specific sample.
The laboratory has to hold responsibility in selecting a suitable EQA provider 
who shall preferably be accredited to ISO 17043. If an EQA program is not available, 
the laboratories shall participate in exchange of samples with referral laboratories 
with a similar methodology and a comparable quality of testing standard.
5. Reporting of results and its standardization
Reporting SPE requires interpretation of the electrophoretic pattern which is 
followed by comments of such an interpretation along with the piece of advice to 
the clinician if indicated. There is a big lacuna in the format of reporting of SPE, 
each laboratorian using his/her own means of interpreting and communicating. It 
is the need of the hour to have a standardized format of reporting SPE for ensuring 
patient safety and clinician follow-up. There are no international guidelines, though 
the working party on standardized reporting of protein electrophoresis which is an 
initiative of the Australasian Association of Clinical Biochemists has come out with 
a standardized format of reporting SPE.
6. Conclusion
In the current scenario, it becomes the responsibility of each and every laboratory 
to ensure that all relevant information is available in a SPE report, easily read, under-
stood, and interpreted by a clinician. This becomes the core of a clinical laboratory 
practice.
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